Open call to physicians and medical institutions to participate in a randomized clinical study

PregnanTech is a start-up company developing the LionessTM – a novel device for delaying and preventing premature birth among pregnant women at risk of spontaneous preterm birth

PregnanTech recently concluded a pilot clinical study among pregnant women at risk of preterm birth

The outcomes affirmed:

  • The device’s safety
  • Demonstrated its ability to keep the cervix elongated
  • Resulted in a low rate of preterm delivery

Furthermore, the study indicated that the LionessTM had a notable positive impact on pregnancy experience and made a significant contribution to alleviating pregnancy related anxiety


Due to the promising results, PregnanTech is initiating a
Multi-center randomized controlled study to evaluate the efficacy of the LionessTM device to increase gestation duration and delay preterm birth among pregnant women with a singleton pregnancy and history of spontaneous preterm birth

If you are interested in hearing more and considering participation, please fill out this initial compatibility questionnaire:


    Private ClinicCommunity / University HospitalOther


    Previous Studies and research experience in the last 5 years

    Assessing Enrollment Rate

    Thank you for filling out this form

    Our team will review the information and get back to you
    We wish you an enjoyable conference
    The PregnanTech team

    Contact us


      17 T’chelet Street
      Misgav, Israel


      Accessibility Toolbar